Luteolin Attenuates Airway Mucus Overproduction via Inhibition of the GABAergic System.
Ontology highlight
ABSTRACT: Airway mucus overproduction is one of the most common symptoms of asthma that causes severe clinical outcomes in patients. Despite the effectiveness of general asthma therapies, specific treatments that prevent mucus overproduction in asthma patients remain lacking. Recent studies have found that activation of GABAA receptors (GABAAR) is important for promoting mucus oversecretion in lung airway epithelia. Here, we report that luteolin, a natural flavonoid compound, suppresses mucus overproduction by functionally inhibiting the GABAergic system. This hypothesis was investigated by testing the effects of luteolin on goblet cell hyperplasia, excessive mucus secretion, and GABAergic transmission using histological and electrophysiological approaches. Our results showed that 10 mg/kg luteolin
SUBMITTER: Shen ML
PROVIDER: S-EPMC5011760 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA